Price rise again! Roche, Novartis, Lilly and Aberdeen will raise the price of 83 drugs this month

In the pharmaceutical industry, it is not uncommon for pharmaceutical companies to significantly increase the prices of best-selling drugs from the beginning of the year to the middle of the year As a result, when the calendar turns to July, many companies are throwing up price rises, suggesting that political pressure on pharmaceutical companies to raise prices may be waning In a report, Wells Fargo analyst David Maris wrote that since July, pharmaceutical companies including Aberdeen, Roche's Genentech, Lilly, GlaxoSmithKline and Sanofi have increased the prices of at least 83 drugs The report cites data from medispan pricerx and tracks only the rise in drug prices of some large and specialty pharmaceutical companies Remember that in the middle of last year, after Pfizer announced dozens of drug price increases, President trump tweeted, naming Pfizer and other pharmaceutical companies "to be ashamed of their actions." Ian read, Pfizer's then chief executive, agreed to postpone the price hike after a phone call with Alex Azar, Secretary of health and human services for universal access, but still plans to raise the prices of 41 prescription drugs in January 2019 Now, the industry seems to be less concerned about rising drug prices "In our view, now that the criticism from politicians and the president seems to have subsided, pharmaceutical companies are looking more actively and broadly for drug prices to rise again," said David Maris However, we believe that this calming down will not continue, and we may see more negative news in the next few months " In June, major and specialty drug makers raised the prices of 35 drugs In July, as many as 83 kinds of drug prices were raised, including: Novartis Suntech raised the price of six products by 9.9%; Albright raised the price of venclexta by 5%; MSD raised the price of insight by 5%; Genentech raised the price of a series of products by 1.5% - 3%; Lilly raised the prices of cyramza, Alimta and Erbitux by 2.5% Since this year, the starting range of drug price increase is 1.5%, among which the largest increase is Tyva, which has raised the price of deammopressin acetate injection by 909%, which is astonishing In recent years, pharmaceutical companies often raise the price of drugs, which has caused a strong backlash The trump administration has been struggling with high drug prices, and Congress is considering its own measures In May last year, the trump Administration issued a drug pricing policy, one of which proposed that drug makers must publish drug prices in TV advertisements The move is intended to further stimulate competition and reduce drug prices Recently, however, the proposal was rejected by the federal court In addition to other proposals to control drug prices, the U.S government is also trying to adjust the drug rebate issue Reference source: Roche, Merck, Novartis and others like prices on 83 meds starting in just: Analyze